Replimune Group Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	209.02	111.12	74.46	146.59	105.95
Short-Term Investments	59.87	372.69	346.21	436.8	289.71
Cash & Short-Term Investments	268.89	483.8	420.67	583.39	395.66
Cash Growth	-44.42%	15.01%	-27.89%	47.45%	-16.93%
Other Receivables	1.62	3.73	4.92	2.94	3.06
Total Trade Receivables	1.62	3.73	4.92	2.94	3.06
Other Current Assets	8.61	8.35	8.08	6.28	5.27
Total Current Assets	279.12	495.88	433.67	592.6	403.98
Net Property, Plant & Equipment	48.62	52.55	52.36	52.35	55.58
Other Long-Term Assets	4.65	2.9	1.7	1.64	1.64
Total Assets	332.39	551.33	487.72	646.59	461.19
Accounts Payable	6.67	12.46	2.58	5.36	3.73
Accrued Expenses	47.52	45.92	33.98	24.7	13.39
Current Portion of Leases	4.04	3.98	3.88	3.76	3.63
Total Current Liabilities	58.23	62.36	40.44	33.83	20.76
Long-Term Debt	83.31	46.38	44.81	28.65	-
Long-Term Leases	24.24	25.81	27.18	28.35	29.21
Other Long-Term Liabilities	0.46	0.94	0.79	0.47	-
Total Long-Term Liabilities	108	73.12	72.78	57.47	29.21
Total Liabilities	166.23	135.49	113.21	91.3	49.96
Common Stock	0.08	0.08	0.06	0.06	0.05
Additional Paid-in Capital	1,423	1,359	1,071	1,035	723.36
Accumulated Other Comprehensive Income	5.4	5.45	4.86	5.73	-0.97
Retained Earnings	-1,263	-948.58	-701.28	-485.49	-311.2
Shareholders' Equity	166.16	415.84	374.51	555.29	411.23
Total Liabilities & Equity	332.39	551.33	487.72	646.59	461.19
Total Debt	111.59	76.17	75.87	60.76	32.84
Net Cash (Debt)	157.3	407.64	344.8	522.63	362.82
Net Cash Growth	-61.41%	18.22%	-34.03%	44.05%	-18.10%
Net Cash Per Share	1.70	5.06	5.18	8.98	6.95
Book Value	166.16	415.84	374.51	555.29	411.23
Book Value Per Share	1.79	5.16	5.63	9.54	7.88
Tangible Book Value	166.16	415.84	374.51	555.29	411.23
Tangible Book Value Per Share	1.79	5.16	5.63	9.54	7.88

SEC Filings: 10-K · 10-Q